These CCR5-expressing cells are trapped in the atherosclerotic plaque where they have a pathologic effect, the use of MVC would impede this process and could, therefore, also be envisioned as a possibly preventative agent against the development of acute coronary syndrome (ACS)14. This evidence concerns the gene CCR5 and acute coronary syndrome.